GB9928430D0 - Screening - Google Patents

Screening

Info

Publication number
GB9928430D0
GB9928430D0 GBGB9928430.9A GB9928430A GB9928430D0 GB 9928430 D0 GB9928430 D0 GB 9928430D0 GB 9928430 A GB9928430 A GB 9928430A GB 9928430 D0 GB9928430 D0 GB 9928430D0
Authority
GB
United Kingdom
Prior art keywords
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9928430.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9928430.9A priority Critical patent/GB9928430D0/en
Publication of GB9928430D0 publication Critical patent/GB9928430D0/en
Priority to EP00988766A priority patent/EP1244786A1/en
Priority to AU25092/01A priority patent/AU2509201A/en
Priority to US10/148,055 priority patent/US20030124554A1/en
Priority to PCT/EP2000/011997 priority patent/WO2001040460A1/en
Priority to JP2001542527A priority patent/JP2003515339A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GBGB9928430.9A 1999-12-01 1999-12-01 Screening Ceased GB9928430D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9928430.9A GB9928430D0 (en) 1999-12-01 1999-12-01 Screening
EP00988766A EP1244786A1 (en) 1999-12-01 2000-11-30 Screening method for compounds capable of modularing egr-1-regulated expression
AU25092/01A AU2509201A (en) 1999-12-01 2000-11-30 Screening method for compounds capable of modularing egr-1-regulated expression
US10/148,055 US20030124554A1 (en) 1999-12-01 2000-11-30 Screening method for compounds capable of modularing egr-1-regulated expression
PCT/EP2000/011997 WO2001040460A1 (en) 1999-12-01 2000-11-30 Screening method for compounds capable of modularing egr-1-regulated expression
JP2001542527A JP2003515339A (en) 1999-12-01 2000-11-30 Screening method for compounds capable of regulating EGR-1 regulatory expression

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9928430.9A GB9928430D0 (en) 1999-12-01 1999-12-01 Screening

Publications (1)

Publication Number Publication Date
GB9928430D0 true GB9928430D0 (en) 2000-01-26

Family

ID=10865529

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9928430.9A Ceased GB9928430D0 (en) 1999-12-01 1999-12-01 Screening

Country Status (5)

Country Link
EP (1) EP1244786A1 (en)
JP (1) JP2003515339A (en)
AU (1) AU2509201A (en)
GB (1) GB9928430D0 (en)
WO (1) WO2001040460A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007106488A2 (en) * 2006-03-13 2007-09-20 Wyeth Modulators of gluconeogenesis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763209A (en) * 1988-09-26 1998-06-09 Arch Development Corporation Methods and materials relating to the functional domains of DNA binding proteins
AUPN855496A0 (en) * 1996-03-07 1996-04-04 Unisearch Limited Prevention of proliferation of vascular cells
ES2205830T3 (en) * 1998-06-02 2004-05-01 Glaxo Group Limited EGR-1 FOR THE PREPARATION OF A MEDICINAL PRODUCT TO TREAT WOUNDS.
IL140533A0 (en) * 1998-07-11 2002-02-10 Glaxo Group Ltd Pharmaceutical uses of nab1 and nab2

Also Published As

Publication number Publication date
AU2509201A (en) 2001-06-12
JP2003515339A (en) 2003-05-07
WO2001040460A8 (en) 2001-11-08
WO2001040460A1 (en) 2001-06-07
EP1244786A1 (en) 2002-10-02

Similar Documents

Publication Publication Date Title
DE50002490D1 (en) Polyester-polyetherblockcopolymere
DE50008011D1 (en) Thixotropierungsmittel
DE50002614D1 (en) Sigma-delta-modulator
GB9904991D0 (en) Genetic screening
GB2356809B (en) Screens
DE50000137D1 (en) Spirofluorenopyrane
GB9922352D0 (en) Screening method
DE10081629D2 (en) Seilzugbefestigung
EP1175268A4 (en) Screening equipment
GB9923075D0 (en) Screening method
EP1237001A4 (en) Screening method
HK1048307A1 (en) Substituted heterocyclyl-2h-chromenes
GB2349217B (en) Compound screening methods
DE50008218D1 (en) Common-rail-injektor
AU141428S (en) Turnpiece
GB9911456D0 (en) Oligohydroxyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives
GB9902696D0 (en) Screening methods
GB2350070B (en) Screening apparatus
PL352101A1 (en) Substituted phenylcyclohexanocarboxyamides
GB9930255D0 (en) Screening method
GB9924929D0 (en) Screening apparatus
GB9928430D0 (en) Screening
DE50005334D1 (en) Tricyclische benzoylcyclohexandion-derivate
AU140373S (en) Bumbag
GB9901979D0 (en) Screening device

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)